Position in INCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,400
+$6,790 QoQ
Shares Held
19,455
0.0% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 16 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MOORE CAPITAL MANAGEMENT, LP holds $55,694,124 across 7 Drug Manufacturers - Specialty & Generic names. INCR ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,430,654 | $22,718,785 | |
| 2 | ZTS |
Zoetis Inc.
|
202,749 | $14,569,543 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
848,336 | $8,483,360 | |
| 4 | PRGO |
PERRIGO Co plc
|
566,924 | $5,890,340 | |
| 5 | ALKS |
Alkermes plc.
|
76,540 | $4,010,696 | |
| 6 | INCR |
Intercure Ltd.
This page
|
19,455 | $21,400 | |
| 7 | ALVO |
Alvotech
|
50,000 | $0 |
All Filings in INCR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,400 | 97,273 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,610 | 97,273 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,703 | 97,273 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $31,905 | 97,273 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,598 | 97,273 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $27,236 | 97,273 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $30,932 | 97,273 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $39,103 | 97,273 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $52,721 | 97,273 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $25,096 | 97,273 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||